PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 35401395-0 2022 KCNQ2-Related Neonatal Epilepsy Treated With Vitamin B6: A Report of Two Cases and Literature Review. Vitamin B 6 45-55 potassium voltage-gated channel subfamily Q member 2 Homo sapiens 0-5 26446091-0 2016 Seizures Due to a KCNQ2 Mutation: Treatment with Vitamin B6. Vitamin B 6 49-59 potassium voltage-gated channel subfamily Q member 2 Homo sapiens 18-23 26446091-2 2016 Whole-exome sequencing was used to identify a de novo mutation (c.629G>A; p.Arg210His) in KCNQ2 in a 7-year-old patient whose neonatal seizures showed a response to pyridoxine and who had a high plasma to CSF pyridoxal 5"-phosphate ratio, usually indicative of an inborn error of vitamin B6 metabolism. Vitamin B 6 283-293 potassium voltage-gated channel subfamily Q member 2 Homo sapiens 93-98 26446091-4 2016 A review of the literature was performed to assess the effectiveness of vitamin B6 treatment in patients with a KCNQ2 channelopathy. Vitamin B 6 72-82 potassium voltage-gated channel subfamily Q member 2 Homo sapiens 112-117 28420012-3 2017 Recently, there are indications that some patients with KCNQ2 NEE show seizure response to vitamin B6 (VB6) therapy. Vitamin B 6 91-101 potassium voltage-gated channel subfamily Q member 2 Homo sapiens 56-61